Europe Fetal and Neonatal Monitoring Market Size

Europe Fetal & Neonatal Monitoring Market Analysis

The Europe fetal and neonatal monitoring market is expected to register a CAGR of 6.2% over the forecast period.

COVID-19 had a significant impact on the growth of the market owing to the strict regulation imposed on the European population. Due to such stringent regulations, the demand for fetal and neonatal monitors was impacted during the initial phase of the pandemic outbreak. Though newborns are at lower risk of developing COVID-19 infection, the utmost care, and monitoring are required, which involves continuous monitoring of blood oxygen levels and heartbeat. Thus, the COVID-19 pandemic has boosted the demand for fetal and neonatal monitoring, and the market is expected to follow the same traction during the forecast period of the study.

Fetal and neonatal monitoring devices are vital tools that are routinely used in gynecology and obstetrics interventions to examine fetal health during labor and delivery. These devices are thus designed for the unique needs of newborn babies. The prevalence of preterm births has increased in recent decades, and these preterm newborns are found to be prone to various diseases and infections. For instance, according to the research article published in the European Journal of Pediatrics, in 2021, the estimated rate of preterm births in Europe was 8.7, which is one of the major causes of death in early childhood in the region. Preterm babies often require special care in the neonatal intensive care unit (NICU), owing to which the demand for neonatal devices is also increasing, which is expected to act as a key driving force for the studied market.

Additionally, the increasing strategic activities by various market players, such as product launches and developments coupled with awareness activities in Europe regarding fetal and neonatal monitoring, are also expected to contribute to the growth of the market over the forecast period. For instance, in May 2021, Medtronic plc launched the SonarMed airway monitoring system. The Sonarmed airway monitoring system utilizes acoustic technology to check for endotracheal tube obstruction and verify position in real-time, giving clinicians vital information required to make more informed, life-saving decisions for Neonates and Infants. Moreover, in March 2022, International Patient Organization for Primary Immunodeficiency (IPOPI) and International Society for Neonatal Screening (ISNS), and the European Society for Immunodeficiencies (ESID) launched the Screen4Rare website. It is a multi-stakeholder platform aiming to exchange knowledge and best practices on newborn screening for rare diseases. Such launches by various organizations are expected to increase awareness among the European population regarding fetal and neonatal health monitoring, thereby contributing to the growth of the market. Hence, these newborns are kept under surveillance using monitoring equipment. These factors have increased the demand for monitoring devices and equipment, which has also driven technological advancements in the equipment.

Thus, the high prevalence of preterm births, frequent product launches, and rising awareness among the European population are expected to fuel the growth of the market over the forecast period. However, the regulatory guidelines for market approval are also very stringent, which dissuades many manufacturers from entering the region.